Total Payments
$27,815
2024 Payments
$3,206
Companies
6
Transactions
25
Payment Breakdown by Category
Consulting$21,537 (77.4%)
Travel$3,846 (13.8%)
Food & Beverage$1,432 (5.1%)
Other$1,000 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,537 | 7 | 77.4% |
| Travel and Lodging | $3,846 | 10 | 13.8% |
| Food and Beverage | $1,432 | 7 | 5.1% |
| Honoraria | $1,000 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $12,222 | 11 | $0 (2017) |
| F. Hoffmann-La Roche AG | $10,274 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,100 | 1 | $0 (2022) |
| Sage Therapeutics, Inc. | $1,072 | 1 | $0 (2022) |
| Genentech, Inc. | $104.33 | 1 | $0 (2018) |
| Hoffmann-La Roche Limited | $42.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,206 | 2 | F. Hoffmann-La Roche AG ($3,206) |
| 2022 | $5,172 | 2 | E.R. Squibb & Sons, L.L.C. ($4,100) |
| 2019 | $6,114 | 6 | F. Hoffmann-La Roche AG ($6,072) |
| 2018 | $1,101 | 4 | F. Hoffmann-La Roche AG ($996.38) |
| 2017 | $12,222 | 11 | Teva Pharmaceuticals USA, Inc. ($12,222) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $3,105.00 | General |
| 11/06/2024 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $101.02 | General |
| 08/09/2022 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,072.00 | General |
| 03/30/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,100.00 | General |
| 09/25/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $1,660.00 | General |
| Category: None | ||||||
| 03/16/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: None | ||||||
| 03/16/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $783.21 | General |
| Category: None | ||||||
| 03/16/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $325.38 | General |
| Category: None | ||||||
| 03/16/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $303.00 | General |
| Category: None | ||||||
| 02/08/2019 | Hoffmann-La Roche Limited | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $42.70 | General |
| Category: None | ||||||
| 11/09/2018 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $104.33 | General |
| 08/29/2018 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $445.62 | General |
| Category: None | ||||||
| 08/29/2018 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $330.76 | General |
| Category: None | ||||||
| 08/29/2018 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $220.00 | General |
| Category: None | ||||||
| 05/25/2017 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: Central Nervous System | ||||||
| 05/04/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Consulting Fee | Cash or cash equivalent | $4,300.00 | General |
| Category: Central Nervous System | ||||||
| 05/04/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Travel and Lodging | In-kind items and services | $540.52 | General |
| Category: Central Nervous System | ||||||
| 05/04/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Travel and Lodging | In-kind items and services | $221.00 | General |
| Category: Central Nervous System | ||||||
| 05/03/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $343.49 | General |
| Category: Central Nervous System | ||||||
| 05/03/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Travel and Lodging | In-kind items and services | $229.37 | General |
| Category: Central Nervous System | ||||||
| 03/23/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Consulting Fee | Cash or cash equivalent | $4,300.00 | General |
| Category: Central Nervous System | ||||||
| 03/23/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Travel and Lodging | In-kind items and services | $517.98 | General |
| Category: Central Nervous System | ||||||
| 03/23/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Travel and Lodging | In-kind items and services | $280.00 | General |
| Category: Central Nervous System | ||||||
| 03/22/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $317.69 | General |
| Category: Central Nervous System | ||||||
| 03/22/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Travel and Lodging | In-kind items and services | $171.86 | General |
| Category: Central Nervous System | ||||||
About Dr. Christopher Ross, M.D
Dr. Christopher Ross, M.D is a Psychiatry healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245268630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Ross, M.D has received a total of $27,815 in payments from pharmaceutical and medical device companies, with $3,206 received in 2024. These payments were reported across 25 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($21,537).
Ad
Practice Information
- Specialty Psychiatry
- Location Baltimore, MD
- Active Since 06/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1245268630
Products in Payments
- SD809-TD (Drug) $11,222
- Non-Covered Product (Drug) $7,111
- AUSTEDO (Drug) $1,000
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Baltimore
John Vaeth, Md, MD
Psychiatry — Payments: $2.0M
Psychiatry $2.0M
Scott Aaronson, M.d, M.D
Psychiatry — Payments: $414,719
Psychiatry $414,719
Dr. Robert Lehman, M.d, M.D
Psychiatry — Payments: $210,729
Psychiatry $210,729
Paul Rosenberg, M.d, M.D
Psychiatry — Payments: $162,959
Psychiatry $162,959
Dr. Karen Anderson, M.d, M.D
Psychiatry — Payments: $158,684
Psychiatry $158,684
Orlando Davis, M.d, M.D
Psychiatry — Payments: $131,372
Psychiatry $131,372